📌 Key Takeaways
- Topic: Amorphous vs Crystalline Silica: Structure, Safety and Uses Compared
- Keywords: silica aerogel powder
- Published: 2026-11-20 02:51:03
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Sand for Glass: Iron Content, Grades and Specifications
- Silica vs Silicon: What Is the Difference?
- Metal compound NPs/MSNs nanocomposites
- What Is the Formula for Silicon Dioxide? SiO₂ Explained
- Silica 99.99% (4N): Specifications, Impurity Limits and Applications
- Silica Uses: Complete List of Applications by Industry
Silica for Powder Coatings: Flow Aid, Matting and Anti-Caking Functions
What is silica (SiO₂)?
silica for floor coatings Joglekar, M., Roggers, R. A., Zhao, Y. & Trewyn, B. G. Interaction influences of mesoporous silica nanoparticles with different morphologies on human red blood cells. RSC Adv. 3, 2454-2461 (2013). Article CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
Quechen silica
What drives silica raw material prices?
silica manufacturer China With the rapid expansion of nanotechnology, nanomaterials have demonstrated great promise in the biomedical field due to their outstanding physicochemical properties. A variety of nanoformulations have been widely explored and developed for cargo delivery, 1, 2, 3, 4, 5 sickness diagnosis, 6, 7, 8, 9 and therapeutic purposes. 10, 11, 12, 13 Compared to macroscale counterparts, nanoformulations always enjoy the distinctive merits, including higher bioavailability, cut down toxic effects and boosted selectivity, in the living organism. 14 Typically, nanoformulations contain two major categories: organic and inorganic nanoformulations. 14, 15 Organic ones such as liposomes and polymers have been demonstrated to be a really effective and secure class of drug carriers, as evidenced by the fact that Doxil l is the first American Food and Drug Administration (FDA)-approved nanoliposomal drug formulation, 16 and the recently reported development of two lipid nanoparticles (NPs)-based COVID-19 mRNA vaccines (BNT162b2 and mRNA-1273). 17 For inorganic NPs-based formulations, though they are slightly inferior to organic NPs-based formulations in terms of biocompatibility and safety, they are superior to organic NPs-based formulations in terms of stability and drug delivery efficiency. Importantly, some distinctive properties possessed by inorganic NPs such as optical, ultrasonic, magnetic and catalytic properties have given rise to some novel NPs-based therapies, i.e., photothermal therapy (PTT), 18, 19 photodynamic therapy (PDT), 20, 21 sonodynamic therapy (SDT), 22, 23 chemodynamic therapy (CDT) 24, 25 and nanozyme-based catalytic therapy. 26, 27 Encouragingly, inorganic NPs are also steadily moving to the clinical stage, with about 25 inorganic nanomedicines approved for clinical use. 28
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.